Dahlbäck B
J Clin Invest. 1980 Sep;66(3):583-91. doi: 10.1172/JCI109890.
Factor V was isolated from human plasma by barium citrate adsorption, polyethylene glycol fractionation, DEAE-Sepharose CL-6B chromatography, ammonium sulfate fractionation, and gel chromatography on Ultrogel 22. Degradation of Factor V during purification was largely prevented by ample use of inhibitors of proteolytic enzyme. The purified Factor V was a stable, single-chain molecule with an apparent molecular weight of 330,000. Activation of human Factor V by thrombin resulted in a 10- to 15-fold increase in activity. The activation pattern as monitored by sodium dodecyl sulfate polyacrylamide gel electrophoresis was compared with that of bovine Factor V. Differences in the patterns of thrombin activation were noticed between the two species, whereas the final products were similar. The products of human Factor V activation are two closely spaced doublets, one with an apparent molecular weight of approximately 110,000, and the other, approximately 72,000. An antibody was raised against the purified protein. Crossed immunoelectrophoresis showed that the antibody recognized Factor V both before and after activation with thrombin.
通过柠檬酸钡吸附、聚乙二醇分级分离、DEAE-琼脂糖CL-6B柱层析、硫酸铵分级分离以及在Ultrogel 22上进行凝胶层析,从人血浆中分离出因子V。在纯化过程中,通过大量使用蛋白水解酶抑制剂,很大程度上防止了因子V的降解。纯化后的因子V是一种稳定的单链分子,表观分子量为330,000。凝血酶对人因子V的激活导致活性增加10至15倍。通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳监测的激活模式与牛因子V的激活模式进行了比较。注意到两种物种在凝血酶激活模式上存在差异,而最终产物相似。人因子V激活的产物是两个紧密相邻的双峰,一个表观分子量约为110,000,另一个约为72,000。制备了针对纯化蛋白的抗体。交叉免疫电泳显示,该抗体在凝血酶激活前后均能识别因子V。